Skip to main content
. 2023 Aug 1;15:17588359231189425. doi: 10.1177/17588359231189425

Figure 1.

Figure 1.

Flow chart of patients: enrollment and outcomes.

HCC, hepatocellular carcinoma; TKI, tyrosine kinase inhibitor.